These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26031307)

  • 1. The sactibiotic subclass of bacteriocins: an update.
    Mathur H; Rea MC; Cotter PD; Hill C; Ross RP
    Curr Protein Pept Sci; 2015; 16(6):549-58. PubMed ID: 26031307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.
    Murphy K; O'Sullivan O; Rea MC; Cotter PD; Ross RP; Hill C
    PLoS One; 2011; 6(7):e20852. PubMed ID: 21760885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a variant of subtilosin A with hemolytic activity.
    Huang T; Geng H; Miyyapuram VR; Sit CS; Vederas JC; Nakano MM
    J Bacteriol; 2009 Sep; 191(18):5690-6. PubMed ID: 19633086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thuricin Z: A Narrow-Spectrum Sactibiotic that Targets the Cell Membrane.
    Mo T; Ji X; Yuan W; Mandalapu D; Wang F; Zhong Y; Li F; Chen Q; Ding W; Deng Z; Yu S; Zhang Q
    Angew Chem Int Ed Engl; 2019 Dec; 58(52):18793-18797. PubMed ID: 31565827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial Labionin-Containing Peptides and Sactibiotics: Unusual Types of Antimicrobial Peptides with Potential Use in Clinical Settings (a Review).
    Varella Coelho ML; de Souza Duarte AF; do Carmo de Freire Bastos M
    Curr Top Med Chem; 2017; 17(10):1177-1198. PubMed ID: 27697045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous expression of thuricin CD immunity genes in Listeria monocytogenes.
    Mathur H; O'Connor PM; Cotter PD; Hill C; Ross RP
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3421-8. PubMed ID: 24709257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in synthetic analogues of lantibiotics: What can we learn from these?
    Tabor AB
    Bioorg Chem; 2014 Aug; 55():39-50. PubMed ID: 24877613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formicin - a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576.
    Collins FWJ; O'Connor PM; O'Sullivan O; Rea MC; Hill C; Ross RP
    Microbiology (Reading); 2016 Sep; 162(9):1662-1671. PubMed ID: 27450592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.
    Rea MC; Sit CS; Clayton E; O'Connor PM; Whittal RM; Zheng J; Vederas JC; Ross RP; Hill C
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9352-7. PubMed ID: 20435915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Mode of Action of the Sactibiotic Thuricin CD.
    Mathur H; Fallico V; O'Connor PM; Rea MC; Cotter PD; Hill C; Ross RP
    Front Microbiol; 2017; 8():696. PubMed ID: 28473822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells.
    Mathur H; Rea MC; Cotter PD; Hill C; Ross RP
    Gut Pathog; 2016; 8():20. PubMed ID: 27257437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.
    Xin B; Zheng J; Xu Z; Song X; Ruan L; Peng D; Sun M
    Appl Environ Microbiol; 2015 Mar; 81(5):1765-74. PubMed ID: 25548056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtilosin Prevents Biofilm Formation by Inhibiting Bacterial Quorum Sensing.
    Algburi A; Zehm S; Netrebov V; Bren AB; Chistyakov V; Chikindas ML
    Probiotics Antimicrob Proteins; 2017 Mar; 9(1):81-90. PubMed ID: 27914001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and mode of action of lantibiotics.
    Chatterjee C; Paul M; Xie L; van der Donk WA
    Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of thioether-bridged bacteriocins.
    Lohans CT; Vederas JC
    J Antibiot (Tokyo); 2014 Jan; 67(1):23-30. PubMed ID: 24022605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of antimicrobial activity of the bacteriocin subtilosin A.
    Shelburne CE; An FY; Dholpe V; Ramamoorthy A; Lopatin DE; Lantz MS
    J Antimicrob Chemother; 2007 Feb; 59(2):297-300. PubMed ID: 17213266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The species-specific mode of action of the antimicrobial peptide subtilosin against Listeria monocytogenes Scott A.
    van Kuijk S; Noll KS; Chikindas ML
    Lett Appl Microbiol; 2012 Jan; 54(1):52-8. PubMed ID: 22040458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.